Healthcare -
Biotechnology - NASDAQ - US
$ 1.5547
1.61 %
$ 16.6 M
Market Cap
-1.45
P/E
MRKR - STOCK-BASED COMPENSATION
Stock-based Compensation MRKR - Marker Therapeutics, Inc.
858 K
LAST VALUE
-62.06%
2 YEAR CAGR
-44.54%
5 YEAR CAGR
20.58%
10 YEAR CAGR